Log In
BCIQ
Print this Print this
 

hRPC cells (formerly ReN003)

  Manage Alerts
Collapse Summary General Information
Company ReNeuron Group plc
DescriptionExpanded human allogeneic neural retinal progenitor cells extracted from neural retina
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationRetinitis
Indication DetailsTreat retinitis pigmentosa (RP)
Regulatory Designation U.S. - Fast Track (Treat retinitis pigmentosa (RP));
U.S. - Orphan Drug (Treat retinitis pigmentosa (RP));
EU - Orphan Drug (Treat retinitis pigmentosa (RP))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/18/2011

Undisclosed

0

Undisclosed

Get a free BioCentury trial today